AURANSA
Auransa is a clinical stage drug development company who aims to invent high value, novel drugs for hard-to-treat diseases like cancer, auto-immune and neurological disorders using its proprietary AI platform and drug discovery expertise. The company's platform is used to understand biology of diseases at subtype level resolution, enabling it to predict compounds and targets of novel pharmacology for responder patient population. Current internal drug pipeline includes a first-in-class investigational new drug for cancer in clinical trials. Auransa has partnership with companies and institutions in the biopharma industry.
AURANSA
Industry:
Artificial Intelligence (AI) Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2014-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.auransa.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
18.5 M USD
Technology used in webpage:
Euro Amazon Nginx U.S. Server Location Amazon SSL Amazon California Region Nginx 1.17
Similar Organizations
Dignify Therapeutics
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Spring Discovery
Spring Discovery accelerates the discovery of therapies for aging by targeting the biological processes of aging itself.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Advisors List
Current Employees Featured
Founder
Investors List
Future Shape
Future Shape investment in Series A - Auransa
11.2 Capital
11.2 Capital investment in Series A - Auransa
Harmonix Fund
Harmonix Fund investment in Series A - Auransa
DCVC
DCVC investment in Series A - Auransa
Lux Capital
Lux Capital investment in Series A - Auransa
AME Cloud Ventures
AME Cloud Ventures investment in Series A - Auransa
DCVC
DCVC investment in Seed Round - Auransa
Official Site Inspections
http://www.auransa.com Semrush global rank: 8.25 M Semrush visits lastest month: 595
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Auransa"
Auransa - Crunchbase Company Profile & Funding
Organization. Auransa . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Auransa is a clinical stage drug development …See details»
About - Auransa
Our leadership team, led by Co-Founder and CEO, Pek Lum, Ph.D., has experience in discovering and developing new drugs at major pharmaceutical companies. Our industry …See details»
Auransa Company Profile | Management and Employees List
Auransa Profile and History Founded in 2014, Auransa is an artificial intelligence (AI)-driven biotechnology company developing precision medicines in areas of significant unmet medical …See details»
Auransa - LinkedIn
At Auransa, we often re-discover known targets for disease indications using our de novo biology first approach. In the right circumstances, AI-guided discovery can reinforce the rationale for ...See details»
Auransa Company Profile 2024: Valuation, Funding & Investors
Auransa General Information Description. Developer of a drug discovery platform designed to research pharmacology from vast amounts of genomics data collected from human disease …See details»
Auransa Company Profile - Office Locations, Competitors ... - Craft
Auransa Summary. Company Summary. Overview. Auransa is a company that develops clinical-stage and AI-native biopharma platforms. It is used to study molecular disease subtypes and …See details»
Auransa - Company Profile - Tracxn
Sep 14, 2024 Auransa ranks 746th among 2706 active competitors. 698 of its competitors are funded while 460 have exited. Overall, Auransa and its competitors have raised over $30.2B in …See details»
AURANSA INC. Company Profile | Palo Alto, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AURANSA INC. of Palo Alto, CA. Get the latest business insights from Dun & Bradstreet.See details»
Auransa - Org Chart, Teams, Culture & Jobs - The Org
View Auransa's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Auransa - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Auransa . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. Number of Board …See details»
Auransa - Updates, News, Events, Signals & Triggers - Crunchbase
Auransa is focused on developing novel therapeutic agents, with research into amidine analogs for treating bacterial and fungal infections, including those caused by gram-negative and gram …See details»
Auransa - Overview, News & Similar companies | ZoomInfo.com
Auransa to Participate in BioCentury-BayHelix China Healthcare Summit 2019 PALO ALTO, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Auransa, Inc., an artificial intelligence (AI) …See details»
Auransa Inc. - Company info. interviews, news - BiopharmaTrend
Auransa Inc. is an AI-driven pharmaceutical startup focusing on developing precise medicines for cancer, aging-related diseases and other disorders. We are a group of veteran drug …See details»
Contact - Auransa
Auransa is committed to protecting and respecting your privacy. We don't collect personal data and we don't use cookies to collect personally identifiable information about visitors to this …See details»
Auransa - Pharmaceutical Technology
Auransa Inc (Auransa) is a artificial intelligence (AI) driven biotechnology company that develop precise medicines for cancer, aging-related diseases and other disorders. The company is …See details»
Press - Auransa
Auransa Announcements. PRESS RELEASES PUBLICATIONS Featured. Aug 7, 2024. First patient in Asia receives AU409 following the ongoing first-in-human clinical trial in the US for …See details»
Platform — Auransa
Our AI platform harnesses available, multi-omics, human disease data to quickly arrive at a short list of compound candidates, for the most responsive patients.See details»
Auransa, Polaris harness AI, quantum computing to discover …
Aug 16, 2022 Auransa and Polaris Quantum Biotech first teamed up last year, bringing together Auransa’s artificial intelligence (AI) capabilities and Polaris’ quantum computing (QC) based …See details»
Auransa Announces Successful First Patient Dosed in Phase 1 …
Auransa is a clinical-stage, AI-native biopharma that mines massive data for therapeutic gold to raise the standard of cancer care. The company’s platform uses AI and available human …See details»